Pasithea Therapeutics appoints Alfred J. Novak to board; two director changes

Pasithea Therapeutics Corp.

Dr. Yassine Bendiabdallah resigned from board on Sept 14, 2022, with no disagreement.
Dr. Lawrence Steinman resigned from audit committee, remaining on board and as chair of nominating committee.
Alfred J. Novak appointed to board and audit committee; experienced healthcare executive and former CEO/CFO.
Mr. Novak previously served on boards of Dova Pharmaceuticals (DOVA), LivaNova (LIVN), and others.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Yassine Bendiabdallah

Director

KTTA · Pasithea Therapeutics Corp.

Effective: 2022-09-14
Filed: September 20, 2022, 7:59 PM ET

On September 14, 2022, Dr. Yassine Bendiabdallah resigned from the board of directors (the “Board”) of Pasithea Therapeutics Corp. (the “Company”).

Appointed

Alfred J. Novak

Director

KTTA · Pasithea Therapeutics Corp.

Effective: 2022-09-14
Filed: September 20, 2022, 7:59 PM ET

Concurrently, the Board appointed Alfred J. Novak to the Board and to its audit committee.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Yassine Bendiabdallah resigned as Director at Pasithea Therapeutics Corp..

Action: resigned
Role: Director

Exact text from the filing

On September 14, 2022, Dr. Yassine Bendiabdallah resigned from the board of directors (the “Board”) of Pasithea Therapeutics Corp. (the “Company”).

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Alfred J. Novak was appointed as Director at Pasithea Therapeutics Corp..

Action: appointed
Role: Director

Exact text from the filing

Concurrently, the Board appointed Alfred J. Novak to the Board and to its audit committee.

View on SEC.gov

Pasithea Therapeutics Corp. filing history →

Source: SEC EDGAR

accession 0001213900-22-057435

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.